Definium Therapeutics to Report Third Quarter 2026 Financial Results on November 9, 2026
Business Wire•29/10/2026•16:01 ET
0
Key Highlights
- ➤Definium Therapeutics will report Q3 2026 financial results November 9, 2026
- ➤Webcast begins at 4:30 p.m. EST with recent business highlights discussion
- ➤Definium Therapeutics trades on Nasdaq under ticker DFTX
Definium Therapeutics to Report Third Quarter 2026 Financial Results on November 9, 2026
Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a webcast at 4:30 p.m. EST on Monday, November 9, 2026 to report financial results for the third quarter ended September 30, 2026, and discuss recent business highlights.
Get started
Create a free account to read the full story.